ExodusPoint Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,000
| Closed | -$172K | – | 1392 |
|
|
2025
Q1 | $172K | Buy |
+20,000
| New | +$172K | ﹤0.01% | 1254 |
|
|
2024
Q4 | – | Sell |
-127,270
| Closed | -$723K | – | 1396 |
|
|
2024
Q3 | $723K | Buy |
+127,270
| New | +$723K | ﹤0.01% | 1011 |
|
|
2023
Q4 | – | Sell |
-10,131
| Closed | -$66K | – | 1396 |
|
|
2023
Q3 | $66K | Sell |
10,131
-65,898
| -87% | -$429K | ﹤0.01% | 1559 |
|
|
2023
Q2 | $618K | Sell |
76,029
-20,556
| -21% | -$167K | 0.01% | 1193 |
|
|
2023
Q1 | $828K | Sell |
96,585
-40,532
| -30% | -$347K | 0.01% | 1107 |
|
|
2022
Q4 | $1.27M | Buy |
137,117
+84,639
| +161% | +$784K | 0.02% | 830 |
|
|
2022
Q3 | $542K | Sell |
52,478
-125,635
| -71% | -$1.3M | 0.01% | 1311 |
|
|
2022
Q2 | $1.78M | Buy |
178,113
+152,189
| +587% | +$1.52M | 0.02% | 785 |
|
|
2022
Q1 | $319K | Buy |
+25,924
| New | +$319K | ﹤0.01% | 1673 |
|
|
2021
Q4 | – | Sell |
-35,342
| Closed | -$634K | – | 2108 |
|
|
2021
Q3 | $634K | Buy |
+35,342
| New | +$634K | 0.01% | 1214 |
|
|
2021
Q2 | – | Sell |
-25,007
| Closed | -$374K | – | 2254 |
|
|
2021
Q1 | $374K | Buy |
+25,007
| New | +$374K | 0.01% | 1488 |
|
|
2019
Q2 | – | Sell |
-16,200
| Closed | -$49K | – | 1069 |
|
|
2019
Q1 | $49K | Buy |
+16,200
| New | +$49K | ﹤0.01% | 628 |
|